Quarterly report · Q1

Period2022-10-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥3.7bn2022-10-01 → 2022-12-31Cons.Net sales
Revenue¥8.5bn2021-10-01 → 2022-09-30Cons.Net sales (5-year summary)
Revenue¥2.4bn2021-10-01 → 2021-12-31Cons.Net sales
Operating income¥467m2022-10-01 → 2022-12-31Cons.Operating income
Operating income¥550m2021-10-01 → 2021-12-31Cons.Operating income
Ordinary income¥475m2022-10-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥1.1bn2021-10-01 → 2022-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥560m2021-10-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥475m2022-10-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥560m2021-10-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥270m2022-10-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥812m2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥371m2021-10-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥268m2022-10-01 → 2022-12-31Cons.Profit loss
Net income¥383m2021-10-01 → 2021-12-31Cons.Profit loss
Total assets¥14.4bnat 2022-12-31Cons.Assets
Total assets¥9.4bnat 2022-09-30Cons.Assets
Total assets¥8.8bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥6.0bnat 2022-12-31Cons.Liabilities
Total liabilities¥1.5bnat 2022-09-30Cons.Liabilities
Net assets / equity¥8.4bnat 2022-12-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets
Net assets / equity¥7.3bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥5.5bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥6.1bnat 2022-09-30Cons.Cash and deposits
EPS (basic)¥12.422022-10-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥37.622021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.182021-10-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥12.082022-10-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥35.782021-10-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥16.232021-10-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio56.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio81.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio80.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-10-01 → 2022-12-31−¥3m
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2022-12-31−¥3m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2022-12-31−¥346m
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue2022-10-01 → 2022-12-31¥3.0bn
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2022-10-01 → 2022-12-31¥3.0bn
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥2m
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2022-10-01 → 2022-12-31¥803m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue2022-10-01 → 2022-12-31¥123m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2022-10-01 → 2022-12-31¥122m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥1m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2022-10-01 → 2022-12-31−¥18m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2022-10-01 → 2022-12-31¥570m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2022-10-01 → 2022-12-31¥570m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥150,000
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2022-10-01 → 2022-12-31¥28m
—segment totalrevenue2022-10-01 → 2022-12-31¥3.7bn
—segment totalrevenue external2022-10-01 → 2022-12-31¥3.7bn
—segment totalrevenue intersegment2022-10-01 → 2022-12-31¥3m
—segment totalsegment profit2022-10-01 → 2022-12-31¥813m
Reconciling Itemsreconcilingrevenue2021-10-01 → 2021-12-31−¥4m
Reconciling Itemsreconcilingrevenue intersegment2021-10-01 → 2021-12-31−¥4m
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2021-12-31−¥319m
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue2021-10-01 → 2021-12-31¥1.8bn
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue external2021-10-01 → 2021-12-31¥1.8bn
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentrevenue intersegment2021-10-01 → 2021-12-31¥994,000
jpcrp040300-q1r_E30650-000Collective Intelligence Platformreportable segmentsegment profit2021-10-01 → 2021-12-31¥789m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue2021-10-01 → 2021-12-31¥94m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue external2021-10-01 → 2021-12-31¥93m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentrevenue intersegment2021-10-01 → 2021-12-31¥1m
jpcrp040300-q1r_E30650-000Medical Institution Support Platformreportable segmentsegment profit2021-10-01 → 2021-12-31¥19m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue2021-10-01 → 2021-12-31¥495m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue external2021-10-01 → 2021-12-31¥494m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentrevenue intersegment2021-10-01 → 2021-12-31¥2m
jpcrp040300-q1r_E30650-000Preventive Healthcare Platformreportable segmentsegment profit2021-10-01 → 2021-12-31¥60m
—segment totalrevenue2021-10-01 → 2021-12-31¥2.4bn
—segment totalrevenue external2021-10-01 → 2021-12-31¥2.4bn
—segment totalrevenue intersegment2021-10-01 → 2021-12-31¥4m
—segment totalsegment profit2021-10-01 → 2021-12-31¥869m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 355
ItemContextValueUnit
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-09-30pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass